Nigerian varsity begins medical trial of COVID-19 medication

NCDC announces one death, 766 new infections

The Abubakar Tafawa Balewa College Instructing Hospital (ATBUTH), Bauchi, says it has begun biomedical medical trial of medicine utilized in therapy of individuals examined constructive for COVID-19.

Jibrin Yusuf, Chief Medical Director of the hospital, acknowledged this in an interview with the Information Company of Nigeria (NAN) on Friday in Bauchi.

NAN reviews that medical trials are a kind of analysis that research new exams and coverings, and evaluates their results on human well being outcomes.

Mr Yusuf mentioned the analysis codenamed “Solidarity Plus” geared toward evaluating the three medication utilized in therapy of sufferers hospitalised of COVID -19.

In line with him, the Soliderty Plus is a part of the seven research presently ongoing at its newly established Molecular Genetics and Infectious Illness Diagnostic Laboratory.

Mr Yusuf mentioned the laboratory was constructed and outfitted by the Abubakar Tafawa Balewa College (ATBU), Bauchi, with the assist of the Tertiary Training Belief Fund (TETFUND).

He mentioned the laboratory was accredited by the Nigeria Heart for Illness Management (NCDC) because the pioneer molecular lab within the North-East area, including that it targeted on varied illnesses together with COVID-19.

He mentioned that a part of the mandate of the hospital was to supply medical companies, coaching and analysis.